> top > docs > PubMed:33211076 > annotations

PubMed:33211076 JSONTXT

Annnotations TAB JSON ListView MergeView

luoyt2021_800_3

Id Subject Object Predicate Lexical cue
T1 34-56 CI denotes Ranibizumab Biosimilar
T11 80-91 CI denotes Ranibizumab
T12 142-162 DP denotes Macular Degeneration
T13 229-249 DP denotes macular degeneration
T14 853-873 DP denotes macular degeneration
T15 2866-2886 DP denotes macular degeneration
T16 2819-2823 CI denotes SB11
T17 2604-2608 CI denotes SB11
T18 2459-2463 CI denotes SB11
T19 2018-2022 CI denotes SB11
T2 340-362 CI denotes ranibizumab biosimilar
T20 1789-1793 CI denotes SB11
T21 1665-1669 CI denotes SB11
T22 1028-1032 CI denotes SB11
T23 544-548 CI denotes SB11
T24 2788-2799 CI denotes ranibizumab
T25 1036-1047 CI denotes ranibizumab
T3 372-376 CI denotes SB11
T4 2643-2654 CI denotes ranibizumab
T5 2468-2479 CI denotes ranibizumab
T6 2051-2062 CI denotes ranibizumab
T7 1828-1839 CI denotes ranibizumab
T8 1676-1687 CI denotes ranibizumab
T9 577-588 CI denotes ranibizumab

Linmchun_800_3

Id Subject Object Predicate Lexical cue
T10 1036-1047 CI denotes ranibizumab
T11 1676-1687 CI denotes ranibizumab
T12 1828-1839 CI denotes ranibizumab
T13 2051-2062 CI denotes ranibizumab
T14 2468-2479 CI denotes ranibizumab
T15 2643-2654 CI denotes ranibizumab
T16 2788-2799 CI denotes ranibizumab
T17 544-548 CI denotes SB11
T18 1028-1032 CI denotes SB11
T19 1665-1669 CI denotes SB11
T20 1789-1793 CI denotes SB11
T21 2018-2022 CI denotes SB11
T22 2459-2463 CI denotes SB11
T23 2604-2608 CI denotes SB11
T24 2819-2823 CI denotes SB11
T25 142-162 DP denotes Macular Degeneration
T26 229-249 DP denotes macular degeneration
T27 853-873 DP denotes macular degeneration
T28 2866-2886 DP denotes macular degeneration
T5 372-376 CI denotes SB11
T6 34-56 CI denotes Ranibizumab Biosimilar
T7 80-91 CI denotes Ranibizumab
T8 340-362 CI denotes ranibizumab biosimilar
T9 577-588 CI denotes ranibizumab